Info

The Future Grind Podcast: Science | Technology | Business | Futurism

Future Grind explores the future through science, technology, entrepreneurship, and philosophy. Hosted by television producer, entrepreneur, and futurist speaker Ryan O’Shea, Future Grind features interviews with innovators and thought leaders that are working to build our future. Biohacking, transhumanism, artificial intelligence, and robotics are frequent topics of conversation. Show notes and more can be found on futuregrind.org. Questions, press inquiries, and speaking requests, can be emailed to hello@futuregrind.org.
RSS Feed Subscribe in Apple Podcasts
The Future Grind Podcast: Science | Technology | Business | Futurism
2018
November
October
August
July
June
May
April
March
February
January


2017
December
November
October
September
January


2016
October
January


2015
August
July


All Episodes
Archives
Now displaying: Page 1
Apr 5, 2018

The acclaimed television series Orphan Black explores the ethics and implications of transhumanism, cloning, life extension, cybernetic enhancements, gene therapy, and more. Much of the development of these themes was guided by science consultant Cosima Herter, so Ryan O'Shea sat down with her for a behind the scenes look at science of Orphan Black. Even if you're not in #CloneClub, you'll get a lot from this episode!

Cosima has an advanced degree in the history and philosophy of science, and has pursued a PhD in the history of biology. She uses her academic background to bring a level of authenticity to science fiction, and she was instrumental to the creation and production of Orphan Black. There are spoilers in this episode. However, you don’t necessarily need to know the show to enjoy this conversation. The show is simply a lens through which we discuss topics of emerging science and technology.

Show Notes: https://futuregrind.org

Follow along -
Twitter - https://twitter.com/Ryan0Shea
Instagram - https://www.instagram.com/ryan_0shea/
Facebook - https://www.facebook.com/RyanOSheaOfficial/

0 Comments
Adding comments is not available at this time.